Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

PIRAMAL PHARMA LIMITED

Quality Assurance

Vendor assessment Checklist

Annexure 02 VENDOR PROFILE – RAW MATERIAL

(Information to be provided by Vendor)


Material Name(s) proposed to be supplied to PPL :

(i) (ii)

1. Name of the company

2. Company Profile Attached SMF  /Additional information 

3. Website

4. Year of establishment

5. Status of your company Proprietary  / Partnership  / Private Limited  /


Public Limited  / Other  …………………………..

6. Board of Directors i)
ii)
7. Items manufactured

8. Annual Turnover for the previous


three years

9. Drug License No.


(Please attach copy if applicable)

Page 1 of 5
PIRAMAL PHARMA LIMITED
Quality Assurance

Vendor assessment Checklist

10. Office Addresses

Tel. No.:

Contact Person Tel. No.:

Out of Hrs. Tel. Nos.

Fax

E-mail

11. No of Manufacturing units

Address for the Site of Manufacture:


[For the item(s) proposed]

Tel. No.:

Contact Person Tel. No.:

Out of Hrs. Tel. Nos.

Fax

E-mail

Page 2 of 5
PIRAMAL PHARMA LIMITED
Quality Assurance

Vendor assessment Checklist

12. Major Clients

13. Countries of Exports

14. Personnel strength / Number of employees in:


Production area

Quality Control

Research and Development

Quality Assurance
15. Have you been audited and approved for GMP WHO-GMP , MCC , TGA , MHRA ,
by National / International authority? USFDA , ISO , Other 
………………………………………..

Date of the latest audit & Name of authority

Are you willing to provide us with copies of Yes  / No  / Not Applicable 


Certification

16. Can you provide an official GMP certificate for Yes  / No  / Not Applicable 
the product(s)?

17. Is the site a mono production site? Yes  / No 

Page 3 of 5
PIRAMAL PHARMA LIMITED
Quality Assurance

Vendor assessment Checklist

18. Name of API’s, manufactured in the same


manufacturing area.

19. Do you have dedicated facility for following in case you are manufacturing the same?
Production of hormones/steroids Yes  / No  / Not Applicable 

Production of Beta– Lactam / Cephalosporin Yes  / No  / Not Applicable 


antibiotics
Production of material which are derived from Yes  / No  / Not Applicable 
animal source
20. Is there any highly effective substances and toxic materials:
Production Yes  / No 
Packaging Yes  / No 
Storage Yes  / No 
Transport Yes  / No 
21. Is the manufacturing process for the products Yes  / No 
proposed for offering have been validated?
22. Can you provide following documents as a part of Tech Pack:
4.1.1 Process Flow Chart  / Route of Yes  / No  / Not Applicable 
Synthesis  / Method of analysis 
Impurity Profile along with chromatograms  / Yes  / No  / Not Applicable 
Trend data Tabulation 
Trend Data on Residual solvents  / Organic Yes  / No  / Not Applicable 
Volatile Impurities (OVI) 
Trend data on Microbial Profile (As applicable) Yes  / No  / Not Applicable 
Long term  & Accelerated stability data as per Yes  / No  / Not Applicable 
ICH 
Particle size Distribution  / Bulk Density  / Sieve Yes  / No  / Not Applicable 
Analysis 

Page 4 of 5
PIRAMAL PHARMA LIMITED
Quality Assurance

Vendor assessment Checklist

Open part of DMF  / COS Ref. copy  Yes  / No  / Not Applicable 


(For regulatory market)
5.1.1 Working Standards for API Yes  / No  / Not Applicable 
Working Standards for Impurities  and Related Yes  / No  / Not Applicable 
Substances  as applicable
TSE  / BSE  / GMO  certificates (as applicable) Yes  / No  / Not Applicable 
Information on standard pack Yes  / No  / Not Applicable 
Material Safety Data Sheet Yes  / No  / Not Applicable 
23. Do you agree to on-site audit? Yes  / No 

24. Are you willing to inform us prior to the implement major changes in:
Site of Manufacture Yes  / No 
Major production equipment Yes  / No 
Change in the process of manufacture Yes  / No 
Technology Yes  / No 
Quality specification Yes  / No 
Test methods Yes  / No 

Note: Kindly provide all relevant documents against which site has marked availability remarks
as “Yes” and provide justification for which site has marked “No/ Not applicable”.

Suresh Parihar ________________________________


Manager – CPD Quality Assurance Name and Designation of Site Personnel
(Sign & Date)

Page 5 of 5

You might also like